Head-to-head · WeighScore
Premium Health vs WeightRx
By GLP-1 ScorecardUpdated
Score comparison
WeightRx has the higher recorded score — 72.1/100 to 58.8/100.
WeightRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. WeightRx is a telehealth provider publishing compounded semaglutide at $250/mo and compounded tirzepatide at $83/mo.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Premium Health | WeightRx |
|---|---|---|
| WeighScore | 58.8/100 | 72.1/100 |
| Grade | C | C |
| Site position | #410 | #94 |
| Semaglutide | $275/mo (all doses, compounded) | $250/mo (compounded) |
| Tirzepatide | $445/mo (all doses, compounded) | $83/mo (term not published, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #410 · C
FDAWarning letter issued to Premium Health Management Inc. dba Premium Health in February 2026. See the FDA warning-letter database.
Strengths
- All-inclusive membership covers medication, supplies, shipping, and provider visits
- Names three licensed pharmacy partners (Hallandale, Red Rock, Strive)
- Compounded with Vitamin B12 or B6 to aid tolerance
- Free consultation and HIPAA-compliant telehealth via Doxy.me
What to consider
- The LegitScript seal ID published for this provider, #8148613, does not resolve on LegitScript's own CDN — checked August 2026, alongside six seal IDs from other providers that returned normally in the same pass
- Compounded medications are not FDA-approved
- Higher base pricing than many compounded competitors ($275/$445)
- High-dose tiers cost extra ($100-$150/mo)
- FDA issued Premium Health Management Inc. dba Premium Health a warning letter in February 2026; the letter is public in FDA's warning-letter database
Site position #94 · C
Strengths
- The tirzepatide figure is published up front, and it is genuinely low against the field
- Both molecules are offered
- No membership charge is advertised alongside the medication rate
What to consider
- The $83 monthly rate is advertised as '$83/month ($997/year)', which is twelve months of it — no month-to-month rate is separately published, and the terms state that a rate is locked for its full term
- Both product pages linked from the homepage return 404, so the plan terms cannot be read before intake
- Six- and twelve-month plans are non-refundable, and eligible refunds carry a 5% processing fee
- No dose strength is published anywhere, so what the $83 buys is not stated
- The named operator is Twist G Marketing, LLC rather than a clinical entity, and the terms carry a binding arbitration and class-action waiver
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.